OCULAR THERAPEUTIX INC

Watch

Share

OCUL·67576A100·US·Common Stock·Healthcare - Biotechnology-13D/G

OCUL (OCULAR THERAPEUTIX INC) is held by 135 institutional investors as of Q2 2026. Largest holders: FMR LLC ($322.5M), BlackRock, Inc. ($190.3M), Avoro Capital Advisors LLC ($123.1M). Net institutional sentiment: Mixed.

135

Holders

(11 Elite)

$1.4B

Total Value

52% (142)

Consensus

74 buying - 68 selling

13F: Jun 30, 2026Insider & Congress: Updated regularly

Smart Money Verdict

View all

Loading verdict

Institutional (13F)48

Insider (Form 4)65

Activist (13D/13G)75

Congressional (STOCK Act)30

Holder Quality

30

★★★★★

Elite

80

★★★★

Strong

38

★★★

Solid

76

★★

Below

17

★

Weak

Held by 135 funds

11 elite

Who's Trading

Source dates: Price Oct 9, 2026 · Insiders Oct 6, 2026 · Activists Jul 29, 2026 · Congress none

InsiderHSHeier Jeffrey S.Sell $77KOct 2, 2026

InsiderKPKaiser PeterSell $70KOct 2, 2026

InsiderNDNotman DonaldSell $11KAug 31, 2026

Checking access…

View all insider tradesView all activist filings

Top Holders

Top Holders (135)History

AllNewIncreasedHeldDecreasedExitedFirst report

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
FMR LLC	Increased	32.8M(+0.6%)	$322.5M	0.0%	-28.17%	31
BlackRock, Inc.	Increased	19.4M(+20.1%)	$190.3M	0.0%	-22.27%	36
Avoro Capital Advisors LLC	Increased	12.5M(+1.8%)	$123.1M	1.1%	-25.46%	49
VAVANGUARD CAPITAL MANAGEMENT LLC	Increased	8.8M(+1.3%)	$86.7M	0.0%	-30.13%	30
PRICE T ROWE ASSOCIATES INC /MD/	Increased	7.6M(+29.3%)	$74.9M	0.0%	-28.54%	37
STATE STREET CORP	Increased	5.2M(+11.2%)	$51.4M	0.0%	-6.76%	33
GEODE CAPITAL MANAGEMENT, LLC	Increased	5M(+10.9%)	$49.3M	0.0%	-17.40%	32
Point72 Asset Management, L.P.	Decreased	3.3M(-40.5%)	$32.3M	0.0%	-29.73%	0
DIMENSIONAL FUND ADVISORS LP	Increased	2.8M(+328.4%)	$27.3M	0.0%	-25.19%	46
BALYASNY ASSET MANAGEMENT L.P.	Decreased	2.3M(-15.7%)	$22.3M	0.0%	-32.70%	0
VPVANGUARD PORTFOLIO MANAGEMENT LLC	Increased	2M(+23.7%)	$19.4M	0.0%	-29.02%	34
NORTHERN TRUST CORP	Increased	1.8M(+17.9%)	$17.7M	0.0%	-15.66%	33
GOLDMAN SACHS GROUP INC	Increased	1.8M(+58.7%)	$17.3M	0.0%	-27.82%	40
Nuveen, LLC	Increased	1.7M(+312.9%)	$16.7M	0.0%	-21.46%	46
Woodline Partners LP	Unchanged	1.7M	$16.4M	0.1%	-30.43%	0
UBS Group AG	Increased	1.6M(+2.0%)	$15.2M	0.0%	-13.95%	29
AGADAGE CAPITAL PARTNERS GP, L.L.C.	New	1.6M	$15.2M	0.0%	-23.52%	39
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	Increased	1.5M(+5.0%)	$15.1M	0.0%	-21.02%	30
SOSquarepoint Ops LLC	Increased	1.4M(+44.4%)	$13.9M	0.0%	-31.73%	38
Invesco Ltd.	Decreased	1.3M(-12.5%)	$13.2M	0.0%	-22.39%	0

Showing 1-20 of 154

Per page:

1 / 8

OCULOCULAR THERAPEUTIX INC

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYELI LILLY & CO

415 holders · $877.5B

UNHUNITEDHEALTH GROUP INC

415 holders · $299.1B

TMOTHERMO FISHER SCIENTIFIC INC

400 holders · $151.4B

JNJJOHNSON & JOHNSON

397 holders · $414.1B

DHRDANAHER CORP DEL

394 holders · $97.5B

ISRGINTUITIVE SURGICAL INC

393 holders · $111.5B

MRKMERCK & CO INC

390 holders · $230.1B

ABBVABBVIE INC

385 holders · $302.9B

BSXBOSTON SCIENTIFIC CORP

385 holders · $51.8B

ABTABBOTT LABORATORIES

382 holders · $113.8B

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer